MOH — authorised 6 December 1996
- Marketing authorisation holder: AMAG PHARMS INC
- Status: likely_approved
MOH authorised Gastromark on 6 December 1996
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 6 December 1996.
AMAG PHARMS INC holds the Israeli marketing authorisation.